ATAI Life Sciences N.V. (NASDAQ:ATAI), a pharmaceutical company specializing in the development of treatments for mental health conditions with a market capitalization of $263 million, announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback